Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with Type 2 diabetes mellitus~* Treated with metformin within a defined dose range for at least 3 months prior to screening~* BMI= 27-45 kg/m2~* HbA1c value between 7.5% and 11%~Exclusion Criteria:~* Treated with oral anti-diabetic medications other than metformin within 3 months of screening~* Patients treated previously with AC2993~* Patients presently treated with insulin

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- AC2993 5 mcg (0.02 mL) (Type: EXPERIMENTAL): Placebo, then AC2993 5 mcg, then AC2993 5 mcg
- AC2993 10mcg (0.04 mL) (Type: EXPERIMENTAL): Placebo, then AC2993 5 mcg, then AC2993 10 mcg
- Placebo 0.02 mL (Type: PLACEBO_COMPARATOR): Placebo 0.02 mL, then Placebo 0.02 mL, then Placebo 0.02 mL
- Placebo 0.04 mL (Type: PLACEBO_COMPARATOR): Placebo 0.02 mL, then Placebo 0.02 mL, then Placebo 0.04 mL

Based on this trial design, predict the completion outcome and termination type (if applicable).